NICE recommends new drug for relapsing MS

Latest

NICE recommends new drug for relapsing MS

In Latest

NICE has recommended the use of auto-injectable MS drug ofatumumab on the NHS. 

The drug, which is marketed as Kesimpta, is described by manufacturer Novartis as the first self-administered, targeted B-cell therapy for adults with active relapsing remitting multiple sclerosis (RRMS) – the most common form of MS.

NICE concluded that Kesimpta is a cost-effective treatment that can be used as a first line RRMS treatment or after alternative medicines have been used.

The NICE decision comes two weeks after the MHRA granted marketing authorisation for the drug. It applies to the NHS in England in Wales, with the Scottish Medicines Consortium expected to publish its final advice later this year.

“People living with MS need access to a range of different treatment options so they can work with their doctor to find the one that’s best for them,” said David Martin, chief executive officer of the Multiple Sclerosis Trust.

“As the first self-injectable B-cell therapy for RRMS, ofatumumab offers a new way for people living with multiple sclerosis to fit treatment into their lives. Without the need for regular hospital visits, even those who live a long way from a specialist centre will be able to access treatment that could reduce disease activity and help them continue to do the things that matter most to them.”

Record my learning outcomes

Latest

Inspiring stories related to health, fitness and the pursuit of wellbeing

Share:

More like this

bookmark_icon_off
Latest

GPhC gains extension of suspension order in FtP case

Case follows another in July where extension to suspension order was not granted.

1 Min Article

bookmark_icon_off
Latest

Repaglinide out of stock until early May

Repaglinide 1mg and 2mg tablets will be out of stock until early May.

1 Min Article

bookmark_icon_off
Latest

Shingles and skin infections next for PGDs under Pharmacy First Scotland

These conditions to be introduced from 1 March dependent on the approval of PGDs.

1 Min Article

bookmark_icon_off
Latest

Pharmacy withdraws needle exchange service after residents protest

A community pharmacy in south Belfast is to withdraw its needle exchange service after more than 20 years following protests from local residents.

1 Min Article

bookmark_icon_off
Latest

Pharmacy minister describes 'tough' funding talks

Jo Churchill has confirmed the Government is considering additional funding to meet the costs incurred by community pharmacy during the pandemic.

2 Min Article

bookmark_icon_off
Latest

GPs take the lead in 96% of PCNs

The leadership of primary care networks is dominated by doctors, with other primary care professionals almost entirely absent.

1 Min Article

Recommended Learning

Sponsored education

Supporting parents of babies with feeding issues

Common feeding feeding issues, including coloc, reflux and regurgitation, and some of the ways they can be managed

10 Min Module

bookmark_icon_off
Sponsored education

Understanding the impact of dry skin conditions

Learn about the emotional impact of dry and eczema-prone skin, and confidently recommend products for skin treatment and maintenance.

10 Min Module

bookmark_icon_off
Sponsored education

Fungal Nail Roundup

Complete this short interactive module to refresh your knowledge on identifying and treating fungal nail infections, and discover more about a product you can recommend to customers.

5 Min Module

bookmark_icon_off
Sponsored education

Advising on stimulant laxatives

Safely recommend the most effective laxative for every customer with constipation

15 Min Module

Sponsored education

The person behind the patient

This interactive video will introduce three patients with erection problems (EPs) and ask you to work out what the causes might be and how you can help.

4 Min Module

bookmark_icon_off
Sponsored education

Skincare training for pharmacy

Delve into dry skin management and understand how you can make a difference to customers looking for advice, support and product recommendations to help manage their compromised skin.

15 Min Module